Navigation Links
Viscira Delivers Key Presentation to Pharmaceutical Marketing Professionals at Leading Digital Industry Conference
Date:7/8/2010

Company offers seven savvy suggestions for effective interactive healthcare marketing at Digital Pharma West.

(PRWEB) -- Viscira™, a leading provider of interactive and new-media solutions for the life sciences industry, delivered a highly relevant presentation entitled, “Maximizing Return on Interactive” at the Digital Pharma West (DPW) conference last week in San Francisco.

Dave Gulezian, President and CEO of Viscira, spoke about the top do’s and don’ts in interactive healthcare marketing to an interested audience of marketing professionals from top biotech, pharma, and medical device companies. The presentation included specific strategic and tactical recommendations for product marketers who are now beginning the 2011 brand planning process. It also utilized the company’s Flash-based, enhanced slide-deck technology, which continues to grow in adoption across the industry.

“It was exciting to present at an industry event that is rapidly becoming the leading forum for the intersection of technology, innovation, and social media in healthcare marketing,” explains Gulezian. “It was also great to hear that many attendees thought our presentation was very beneficial and timely given their priorities right now”.

Viscira was also a sponsor of the conference, which explored how the interaction among patients, healthcare providers, and pharmaceutical marketers is improved through the use of new technologies and innovations such as social media. The DPW event also attracted presenters from other industry leaders such as Eli Lilly, Amgen, Genentech, and AstraZeneca.

Interested parties can download a copy of the presentation in either PC or MAC format using the web links below:

Viscira Maximizing ROI Presentation - PC Format
https://viscira.sharefile.com/d/sa1fc0b31ebf45429

*Please click on the DPW_PC.exe file after downloading.

Viscira Maximizing ROI Presentation - MAC Format
https://viscira.sharefile.com/d/sd6feca5c8154a57a

*Please click on the DPW_MAC file after downloading.


About Viscira
Viscira is dedicated to the development of new-media communication solutions and interactive software applications for the life sciences industry. Viscira provides a suite of programs that provide best-in-class technology solutions to deliver engaging and memorable content via various electronic channels. For more information about Viscira and the product solutions we offer, please visit the company’s website at www.viscira.com or contact Noel Ashekian at (617) 429-0834.

Press Contact
Noel Ashekian
Marketing Communications Manager - Viscira
Phone: (617) 429-0834
Email: nashekian(at)viscira(dot)com

###

Read the full story at http://www.prweb.com/releases/Viscira/interactivepresentation/prweb4230604.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Looking at AMD Through Patients' Eyes: Viscira Virtual Exhibit Educates Physicians by Personalizing Serious Eye Disease
2. Viscira Announces Version 2.0 of its Online Interactive Slide Kit Builder Application
3. InVitrias Cellastim Delivers Superior Results in Mammalian Cell Culture
4. Plexon Inc Delivers 500th "Harvey Box" : 25 Years of Neural Data Acquisition and Analysis Leads to 500th System Sale
5. Shires New Product Portfolio Delivers Strong Quarterly Performance
6. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI
7. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to The Genome Center at Washington University School of Medicine in St. Louis
8. Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc.
9. Nikon Instruments A1 Confocal Laser Microscope Series With NIS-Elements C Software Delivers Fully Integrated Comprehensive Confocal Imaging Capabilities
10. Cell Biosciences Delivers Next Generation System to Stanford University
11. ICON Delivers New Electronic Solution to Expedite Clinical Trial Adjudication
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Viscira Delivers Key Presentation to Pharmaceutical Marketing Professionals at Leading Digital Industry Conference 
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks ... to industrial engineering, was today awarded as one ... selection of the world,s most innovative companies. Ginkgo ... scale for the real world in the nutrition, ... engineers work directly with customers including Fortune 500 ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
(Date:6/23/2016)... ... 2016 , ... UAS LifeSciences, one of the leading manufacturers ... Probiotics, into Target stores nationwide. The company, which has been manufacturing high quality ... list of well-respected retailers. This list includes such fine stores as Whole Foods, ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
Breaking Biology News(10 mins):